CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 35 filers reported holding CONMED CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,153 | -25.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2023 | $1,538 | -75.0% | 1,000 | -80.0% | 0.00% | – |
| Q1 2023 | $6,143 | +8.4% | 5,000 | 0.0% | 0.00% | – |
| Q4 2022 | $5,665 | -29.2% | 5,000 | -28.6% | 0.00% | – |
| Q3 2022 | $8,000 | 0.0% | 7,000 | 0.0% | 0.00% | – |
| Q2 2022 | $8,000 | -33.3% | 7,000 | 0.0% | 0.00% | – |
| Q1 2022 | $12,000 | 0.0% | 7,000 | 0.0% | 0.00% | – |
| Q4 2021 | $12,000 | +9.1% | 7,000 | 0.0% | 0.00% | – |
| Q3 2021 | $11,000 | -99.3% | 7,000 | -99.3% | 0.00% | -100.0% |
| Q2 2021 | $1,611,000 | +46.2% | 1,000,000 | +41.8% | 0.00% | 0.0% |
| Q1 2021 | $1,102,000 | -27.4% | 705,000 | -35.0% | 0.00% | 0.0% |
| Q4 2020 | $1,517,000 | +34.1% | 1,085,000 | +7.4% | 0.00% | 0.0% |
| Q3 2020 | $1,131,000 | -49.8% | 1,010,000 | -53.1% | 0.00% | -50.0% |
| Q2 2020 | $2,253,000 | – | 2,153,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 50,065,000 | $86,599,000 | 6.97% |
| III Capital Management | 12,488,000 | $21,464,000 | 1.87% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,035,000 | $6,946,000 | 1.55% |
| SHENKMAN CAPITAL MANAGEMENT INC | 6,082,000 | $10,261,000 | 1.29% |
| SSI INVESTMENT MANAGEMENT LLC | 6,448,000 | $11,078,000 | 0.60% |
| MACKAY SHIELDS LLC | 38,008,000 | $65,472,000 | 0.58% |
| Eisler Capital (UK) Ltd. | 9,500,000 | $16,280,000 | 0.27% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 53,974,000 | $93,024,000 | 0.26% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 2,607,000 | $4,493,000 | 0.25% |
| Polar Asset Management Partners Inc. | 10,000,000 | $17,137,000 | 0.18% |